No definition available.
Maternal care for (suspected) damage to fetus from alcohol
MATERNCAREFETUSALCO
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
123 |
4. Check minimum number of eventsNone |
123 |
5. Include endpointsNone |
123 |
6. Filter based on genotype QC (FinnGen only) |
123 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- O35
- Name in latin
- Cura matris propter laesionem [suspectam] fetus ex abusu alcohol matris
Similar endpoints
↥List of similar endpoints to
Maternal care for (suspected) damage to fetus from alcohol
based on the number of shared cases.
Similar with more cases:
- Maternal care for known or suspected fetal abnormality and damage
- Alcohol use disorder, Swedish definition
- Alcohol related diseases, tilastokeskus definition
- Alcohol related diseases and deaths, all endpoints
- Maternal care related to the fetus and amniotic cavity and possible delivery problems
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 998 | 989 | - |
| Only index persons | 962 | 962 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | - |
| Only index persons | 0.04 | 0.04 | - |
| Median age at first event (years) | |||
| Whole population | - | 29.01 | - |
| Only index persons | - | 28.94 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 123 | 123 | - |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | - |
| Median age at first event (years) | 30.11 | 30.11 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 114
- Matched controls
- 1141
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
O35.4
ICD-10 Finland
Maternal care for (suspected) damage to fetus from alcohol
+∞
164.5
114
*
Z2446
NOMESCO Finland
Social worker
37.0
45.7
60
33
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
+∞
42.4
38
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
29.2
31.5
43
23
Z2221
NOMESCO Finland
Medical doctor
10.3
28.3
84
244
N07BB01
ATC
disulfiram; oral
19.7
21.6
33
23
B18.2
ICD-10 Finland
Chronic viral hepatitis C
45.1
20.9
25
7
Z3231
NOMESCO Finland
Registered nurse
7.5
20.4
60
147
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
7.4
20.1
59
144
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
67.4
19.7
22
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
11.6
19.3
38
47
RS120
NOMESCO Finland
NA
+∞
19.3
18
*
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
6.5
19.2
82
321
F32.9
ICD-10 Finland
Depressive episode, unspecified
7.0
17.1
49
110
F10.20
ICD-10 Finland
Alcohol dependence currently independent
47.9
17.0
20
5
N05BA04
ATC
oxazepam; oral
5.8
16.6
61
188
T36
ICD-10 Finland
Poisoning by systemic antibiotics
12.7
16.5
30
31
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
11.0
16.2
32
39
N05AH04
ATC
quetiapine; oral
5.9
15.5
52
141
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
5.4
15.3
59
188
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
5.5
15.0
55
164
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
92.3
15.0
16
*
P15
ICPC
Chronic alcohol abuse
26.6
14.8
20
9
N06AX11
ATC
mirtazapine; oral
4.9
14.2
65
242
Z3232
NOMESCO Finland
Midwife
5.4
13.7
49
139
ZY010
NOMESCO Finland
Hospital outpatient
11.3
13.7
26
29
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
14.1
13.6
23
20
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
15.8
13.1
21
16
F10.25
ICD-10 Finland
Alcohol dependence continuous use
145.3
12.7
13
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
10.9
12.5
24
27
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
15.9
12.5
20
15
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
15.9
12.5
20
15
Z37.0
ICD-10 Finland
Single live birth
4.6
12.1
53
182
ZXE00
NOMESCO Finland
One hour or less
4.2
12.1
73
338
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
11.6
11.9
22
23
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
132.9
11.7
12
*
N05BA01
ATC
diazepam; systemic, rectal
7.5
11.6
28
47
T74.1
ICD-10 Finland
Physical abuse
23.0
11.5
16
8
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
16.2
11.4
18
13
N06AB04
ATC
citalopram; systemic
4.7
11.4
46
144
N05BA12
ATC
alprazolam; oral
7.4
11.4
28
48
WX892
NOMESCO Finland
Monitored bed care
14.0
11.3
19
16
XF400
NOMESCO Finland
ECG with 12 standard connections
7.5
11.2
27
45
Z72.2
ICD-10 Finland
Drug use
48.5
11.2
13
*
F10.24
ICD-10 Finland
Alcohol depence active use
31.5
11.0
14
5
X14
ICPC
Vaginal discharge
11.3
10.8
20
21
Z32.1
ICD-10 Finland
Pregnancy confirmed
4.2
10.7
52
191
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
120.6
10.6
11
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
15.1
10.6
17
13
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
10.8
10.5
20
22
LCH11
NOMESCO Finland
Pharmacologic abortion
5.5
10.4
33
79
Z71.8
ICD-10 Finland
Other specified counselling
4.0
10.3
54
210
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
10.3
10.3
20
23
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.3
10.3
25
42
MAX99
NOMESCO Finland
Assistance to normal delivery
4.0
10.2
51
191
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
9.3
10.2
21
27
P19
ICPC
Drug abuse
44.2
10.2
12
*
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
3.7
10.1
67
316
ZXD10
NOMESCO Finland
Scheduled procedure
3.7
10.0
61
269
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
10.6
10.0
19
21
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
60.3
9.8
11
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
10.1
9.8
19
22
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
4.1
9.7
45
157
RS310
NOMESCO Finland
NA
+∞
9.5
9
*
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
+∞
9.5
9
*
RS122
NOMESCO Finland
NA
+∞
9.5
9
*
P29
ICPC
Psychological sympt/compl other
6.8
9.4
24
43
D01
ICPC
Abdominal pain/cramps general
5.1
9.4
31
77
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
10.0
9.2
18
21
N05AH03
ATC
olanzapine; systemic
7.3
9.2
22
36
P01AB01
ATC
metronidazole; oral, rectal
3.4
8.9
68
348
N05AX08
ATC
risperidone; systemic
7.3
8.8
21
34
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
54.3
8.8
10
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.5
8.7
33
94
IGY99
NOMESCO Finland
Other psychiatric treatment contact
14.3
8.6
14
11
N05BA02
ATC
chlordiazepoxide; systemic
96.9
8.5
9
*
N06AB10
ATC
escitalopram; oral
3.4
8.5
53
232
V03AA01
ATC
NA
+∞
8.4
8
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
+∞
8.4
8
*
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
+∞
8.4
8
*
F61.0
ICD-10 Finland
Mixed personality disorders
18.9
8.3
12
7
N05CF01
ATC
zopiclone; oral
3.7
8.3
42
154
XMA22
NOMESCO Finland
General examination of pregnant woman
4.3
8.2
33
99
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
24.1
8.2
11
5
N03AG01
ATC
valproic acid; systemic, rectal
6.9
8.1
20
34
W01
ICPC
Question of pregnancy
14.5
8.1
13
10
P74
ICPC
Anxiety disorder/anxiety state
7.7
8.0
18
27
N06AX16
ATC
venlafaxine; oral
3.8
7.9
37
128
N05CD07
ATC
temazepam; oral
10.0
7.8
15
17
R2110
NOMESCO Finland
Giving the first information
5.0
7.7
25
60
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.1
7.6
32
100
X23
ICPC
Fear sexually transm dis female
4.3
7.6
29
83
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
4.0
7.5
32
101
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
85.4
7.5
8
*
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
85.4
7.5
8
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
85.4
7.5
8
*
T51.0
ICD-10 Finland
Toxic effect: Ethanol
85.4
7.5
8
*
Z3226
NOMESCO Finland
Physiotherapist
3.9
7.5
33
108
R05
ICPC
Cough
3.4
7.4
43
174
W14
ICPC
Contraception female other
4.5
7.4
27
74
B17.1
ICD-10 Finland
Acute hepatitis C
+∞
7.4
7
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
+∞
7.4
7
*
D10
ICPC
Vomiting
4.7
7.3
25
64
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
7.2
7.3
17
27
P76
ICPC
Depressive disorder
4.9
7.3
24
59
N06AA12
ATC
doxepin; systemic
21.7
7.3
10
5
D25
ICPC
Abdominal distension
21.7
7.3
10
5
F39
ICD-10 Finland
Unspecified mood [affective] disorder
13.2
7.3
12
10
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
32.3
7.3
9
*
ZXD20
NOMESCO Finland
Day surgery
4.5
7.2
26
70
U01
ICPC
Dysuria/painful urination
5.5
7.2
21
45
SPAT1324
SPAT
Screening procedure
0.1
7.1
*
255
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
10.3
7.0
13
14
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
12.0
7.0
12
11
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
18.1
6.9
10
6
D12
ICPC
Constipation
18.1
6.9
10
6
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
18.1
6.9
10
6
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
42.7
6.8
8
*
RS121
NOMESCO Finland
NA
42.7
6.8
8
*
L12
ICPC
Hand/finger symptom/complaint
3.9
6.8
29
91
F31.8
ICD-10 Finland
Other bipolar affective disorders
9.6
6.8
13
15
EBA30
NOMESCO Finland
Excision of root of tooth
13.4
6.7
11
9
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
13.4
6.7
11
9
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
13.4
6.7
11
9
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
13.4
6.7
11
9
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.5
6.7
24
64
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.9
6.7
18
35
WX110
NOMESCO Finland
Local anesthesy
3.6
6.6
98
718
P01
ICPC
Feeling anxious/nervous/tense
3.3
6.5
36
139
B86
ICD-10 Finland
Scabies
15.5
6.5
10
7
K08.3
ICD-10 Finland
Retained dental root
10.2
6.5
12
13
N05AF03
ATC
chlorprothixene; systemic
12.0
6.4
11
10
N06AB06
ATC
sertraline; oral
3.9
6.4
27
84
A46
ICD-10 Finland
Erysipelas
7.0
6.4
15
24
R74
ICPC
Upper respiratory infection acute
2.8
6.4
64
361
SPAT1265
SPAT
Breathalyser
19.3
6.4
9
5
Z72.1
ICD-10 Finland
Alcohol use
19.3
6.4
9
5
P03
ICPC
Feeling depressed
3.6
6.4
30
103
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
8.5
6.3
13
17
TUPKY
NOMESCO Finland
NA
28.4
6.3
8
*
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
+∞
6.3
6
*
RS312
NOMESCO Finland
NA
+∞
6.3
6
*
S72
ICPC
Scabies/other acariasis
+∞
6.3
6
*
F60.2
ICD-10 Finland
Dissocial personality disorder
+∞
6.3
6
*
EB1AA
SPAT
NA
6.2
6.3
16
29
F41.00
ICD-10 Finland
Moderate panic disorder
9.4
6.2
12
14
ZYC01
NOMESCO Finland
Remote contact by phone
9.4
6.2
12
14
D06
ICPC
Abdominal pain localized other
4.2
6.2
23
64
IGY02
NOMESCO Finland
Psychiatric monitoring contact
8.0
6.1
13
18
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
16.1
6.0
9
6
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
16.1
6.0
9
6
P27
ICPC
Fear of mental disorder
16.1
6.0
9
6
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.4
6.0
21
55
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
65
169
7.04
26.50
2.5
1.4
%
1.6
1.3
4.13
60
151
(3028707) Methadone [Presence] in Urine by Screen method
37
53
9.55
26.21
3.1
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
42
71
8.46
25.87
5.7
2.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
45
8.49
20.16
1.4
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
41
91
6.26
18.98
4.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
42
98
5.99
18.38
3.9
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
42
98
5.99
18.38
3.9
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
42
99
5.92
18.16
3.8
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
39
89
5.95
17.40
3.1
2.4
u/l
37.2
28.7
0.45
31
78
(3027008) Opiates [Presence] in Urine
41
98
5.78
17.40
4.0
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
19
19
11.64
17.14
3.6
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
57
6.64
16.07
1.6
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
36
83
5.72
15.77
3.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
19
6
37.01
15.32
1.9
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
29
8.53
14.90
1.8
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
41
117
4.76
13.85
1.7
1.4
—
—
—
0
0
(4198724)
14
13
12.02
13.09
1.7
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
86
448
4.06
12.06
5.8
4.9
umol/l
11.9
9.1
0.85
81
421
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
40
125
4.26
11.84
2.4
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
55
218
3.75
11.57
3.0
2.3
e6/l
0.2
0.4
0.49
46
155
(36304419) Bacteria [Presence] in Urine
55
226
3.59
10.83
2.9
2.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
37
118
4.05
10.54
2.6
2.1
e6/l
1.1
1.0
0.09
18
59
(3000991) Gas panel - Venous blood
20
38
6.09
10.51
7.5
7.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
21
8.00
10.38
1.3
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
112
3.97
9.87
2.7
2.1
e6/l
5.5
4.5
0.18
17
52
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
33
103
4.01
9.62
1.8
2.3
umol/l
10.6
5.4
0.43
28
85
(3009508) Creatinine [Moles/volume] in Urine
52
220
3.36
9.58
4.2
2.9
mmol/l
6.3
8.2
2.09
45
192
(3018095) Leukocytes [#/volume] in Urine
66
323
3.25
9.52
4.1
2.9
e6/l
42.5
62.4
0.29
45
199
(40758558) Short blood count panel - Blood
56
249
3.29
9.49
5.8
5.8
—
—
—
0
0
(3026782) Osmolality of Urine
41
157
3.42
8.76
2.0
2.2
mosm/kgh2o
513.3
569.0
0.57
30
129
(3002582) Erythrocytes [#/volume] in Urine
55
253
3.12
8.64
3.0
2.4
e6/l
15.3
69.6
1.35
46
189
(3023368) Bacteria identified in Blood by Culture
39
148
3.39
8.42
5.5
4.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
81
472
3.10
8.22
2.9
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
48
211
3.09
8.07
2.3
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
32
111
3.54
7.90
1.8
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
70
388
2.87
7.59
2.2
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
41
172
3.08
7.39
2.0
2.2
e6/l
16.9
14.2
0.15
33
147
(3024928) Oxygen saturation in Venous blood
10
6
17.96
6.87
1.3
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
54
274
2.73
6.76
3.5
2.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
27
93
3.44
6.67
1.7
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
33
4.66
5.72
2.8
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
48
246
2.56
5.72
2.7
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
98
704
2.93
5.66
7.1
6.2
u/l
83.6
70.3
1.31
90
659
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
65
387
2.44
5.57
3.7
2.2
—
—
—
0
0
(3012544) pH of Venous blood
17
49
3.87
5.39
4.5
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
27
113
2.78
4.72
1.3
1.5
—
—
—
0
0
(3015736) pH of Urine
65
413
2.22
4.50
4.7
2.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
26
4.55
4.46
1.2
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
26
110
2.73
4.44
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
26
110
2.73
4.44
1.2
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
58
354
2.21
4.42
3.3
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
49
280
2.25
4.38
3.5
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
41
218
2.32
4.34
3.9
3.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
13
7.37
4.24
1.9
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
27
120
2.60
4.18
2.9
2.4
ng/l
48.4
289.7
0.49
12
43
(1761868) Lipid panel - Serum or Plasma
21
434
0.38
4.15
1.5
2.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
73
503
2.11
3.93
5.7
3.6
mmol/l
6.6
6.1
0.50
67
433
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
12
34
3.80
3.87
1.8
3.9
mmol/l
24.3
25.0
0.27
12
34
(40760892) CBC W Ordered Manual Differential panel - Blood
10
289
0.29
3.84
2.3
4.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
5
12.51
3.80
1.3
1.0
%
71.2
70.4
—
6
5
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
25
4.27
3.78
1.2
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
16
5.98
3.73
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
16
5.98
3.73
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
52
322
2.07
3.67
1.7
1.7
pmol/l
96.6
98.2
0.08
18
183
(3009542) Hematocrit [Volume Fraction] of Blood
118
1039
4.34
3.65
21.1
10.1
%
39.4
39.8
0.43
106
899
(42870588) Differential panel, method unspecified - Blood
52
323
2.06
3.63
4.8
5.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
40
225
2.15
3.62
1.6
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
246
0.32
3.59
1.4
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
35
187
2.22
3.59
2.6
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
82
604
2.07
3.53
11.0
7.9
e9/l
4.2
4.0
0.41
64
534
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
72
507
2.01
3.51
2.9
4.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
72
2.76
3.39
2.7
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
66
455
1.97
3.37
6.2
7.2
e9/l
0.0
0.0
0.50
48
367
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
27
133
2.32
3.33
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
27
133
2.32
3.33
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
27
133
2.32
3.33
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
27
133
2.32
3.33
1.2
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
18
73
2.72
3.31
2.6
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
22
414
0.43
3.28
3.9
2.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
143
2.24
3.18
1.3
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
77
567
1.96
3.17
2.6
2.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
89
690
2.05
3.15
6.3
3.9
—
28.4
—
0
10
(3025130) Human papilloma virus identified in Specimen
12
40
3.22
3.06
1.5
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
113
972
3.00
3.00
15.8
8.2
mmol/l
138.8
139.5
3.22
108
938
(3023103) Potassium [Moles/volume] in Serum or Plasma
113
973
2.98
2.97
15.0
8.2
mmol/l
3.9
3.9
0.17
108
933
(3032080) INR in Blood by Coagulation assay
37
219
1.99
2.85
5.2
4.8
inr
1.1
1.0
—
8
85
(3041096) Erythrocytes [Presence] in Urine by Automated
16
326
0.41
2.82
2.8
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
21
100
2.33
2.78
1.4
1.6
nmol/l
1306.2
1055.7
0.39
12
79
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
39
3.00
2.55
1.9
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
21
4.00
2.51
9.6
8.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
21
4.00
2.51
21.4
12.6
%
0.7
0.7
—
8
21
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
21
4.00
2.51
21.4
12.6
%
1.0
0.9
—
8
21
(3000494) Fungus identified in Specimen by Culture
20
98
2.24
2.48
1.3
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
22
3.81
2.41
7.9
2.0
%
0.7
0.7
—
8
22
(3014007) Fractional oxyhemoglobin in Arterial blood
8
22
3.81
2.41
21.4
12.2
%
95.8
95.7
—
8
22
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
108
936
2.26
2.34
12.4
7.7
ml/min/173m2
103.6
98.0
2.71
83
728
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
23
3.64
2.31
1.8
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
45
302
1.77
2.30
1.8
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
13
4.79
2.30
1.7
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
18
4.06
2.29
4.3
2.3
u/ml
13.1
16.7
—
7
18
(3029937) Albumin [Presence] in Urine by Test strip
14
277
0.44
2.23
4.6
3.1
estimate
0.0
0.0
—
6
114
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
24
3.49
2.22
7.9
1.9
%
2.3
1.3
—
8
24
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
75
2.30
2.20
3.1
2.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
8
25
3.35
2.13
1.0
1.3
—
130.3
—
0
8
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
113
1007
2.50
2.13
4.6
5.0
mu/l
1.7
1.6
0.20
103
962
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
10
5.16
2.09
2.8
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
156
0.35
2.08
1.7
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
8
27
3.10
1.97
7.9
2.6
g/l
134.9
128.8
—
8
27
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
11
4.69
1.96
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
49
350
1.66
1.95
1.7
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
19
101
2.04
1.94
2.1
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
68
529
1.64
1.93
5.5
5.0
e9/l
0.5
0.5
0.44
54
472
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
22
3.31
1.91
1.1
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
70
551
1.63
1.88
5.5
5.4
e9/l
0.2
0.2
0.27
57
502
(3006315) Basophils [#/volume] in Blood
68
532
1.62
1.86
5.5
5.0
e9/l
0.0
0.0
0.09
55
471
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
21
118
1.94
1.84
2.7
1.8
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
12
4.29
1.84
18.0
17.3
nmol/l
1429.8
1981.8
—
5
12
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
29
2.88
1.82
1.0
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
30
2.78
1.76
1.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
53
398
1.58
1.68
1.6
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
38
264
1.64
1.65
2.8
2.2
u/l
48.7
54.1
0.51
32
250
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
105
935
1.84
1.59
3.8
3.1
mmol/l
6.0
5.6
1.42
94
883
(21494755) Public health laboratory ask at order entry panel
9
177
0.47
1.56
1.3
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
87
743
1.58
1.50
5.6
3.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
246
1.59
1.43
1.9
1.7
mg/l
0.8
0.7
0.08
23
180
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
114
1056
2.09
1.43
15.5
9.8
mg/l
28.7
17.7
1.76
91
784
(3019198) Lymphocytes [#/volume] in Blood
68
554
1.51
1.42
5.6
5.0
e9/l
2.1
2.0
0.78
57
503
(3021387) Prolactin [Units/volume] in Serum or Plasma
17
100
1.81
1.31
1.4
1.4
mu/l
378.9
260.7
0.46
17
89
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
35
2.37
1.29
2.1
2.2
%
121.1
156.4
—
8
35
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
56
2.06
1.26
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
19
2.70
1.23
1.2
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
35
0.00
1.17
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
67
1.88
1.09
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
118
1122
2.27
1.07
11.6
9.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
38
289
1.46
1.07
1.2
1.4
g/l
2.9
2.0
1.46
17
196
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
46
2.03
1.06
1.6
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
19
125
1.62
1.01
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
97
879
1.49
1.00
3.4
4.5
pmol/l
13.3
14.2
4.15
89
832
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
29
0.00
0.99
0.0
1.0
—
0.6
—
0
13
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
36
2.00
0.98
1.6
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
31
0.00
0.98
0.0
1.8
—
7.0
—
0
16
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
37
1.94
0.95
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
37
1.94
0.95
1.0
1.1
—
—
—
0
0
(4010399)
10
57
1.82
0.86
1.1
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
6
32
1.92
0.83
1.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
30
230
1.40
0.80
1.3
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
25
0.00
0.80
0.0
1.2
—
30.6
—
0
20
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
47
389
1.34
0.78
2.2
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
23
2.22
0.77
2.4
3.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
38
1.89
0.75
1.0
1.1
—
—
—
0
0
(4035726)
10
61
1.70
0.71
1.1
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
105
0.55
0.65
3.7
3.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
88
1.53
0.63
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
23
0.00
0.59
0.0
1.7
—
7.4
—
0
16
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
37
1.65
0.56
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
131
0.66
0.55
1.7
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
6
38
1.61
0.55
1.8
3.8
—
7.4
—
0
5
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
230
0.75
0.49
1.4
1.3
iu/ml
13.5
23.9
—
5
68
(40768804) Tissue Pathology biopsy report
51
449
1.23
0.49
2.0
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
47
1.52
0.48
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
86
801
1.24
0.48
4.6
3.6
mmol/mol
35.5
36.9
0.67
80
771
(3008898) HLA-B27 [Presence]
6
95
0.61
0.44
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
15
0.00
0.41
0.0
1.7
—
135.8
—
0
10
(3004616) Nuclear Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
36
1.40
0.38
1.0
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
78
0.63
0.37
1.0
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
17
138
1.27
0.32
1.4
1.3
iu/l
24.2
22.8
—
10
124
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
98
0.70
0.32
2.0
2.2
—
18.4
—
0
8
(40761535) Cells panel - Urine sediment
7
53
1.34
0.31
5.9
2.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
15
121
1.27
0.30
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
104
1006
1.22
0.28
5.5
4.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
28
247
1.17
0.25
1.8
1.9
mg/l
2.0
2.5
0.90
23
214
(3025941) Bacteria identified in Stool by Culture
9
76
1.20
0.25
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
40
1.26
0.22
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
40
1.26
0.22
1.6
1.6
%
92.4
98.6
—
5
40
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(4281824)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
38.7
—
0
10
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
12
0.00
0.21
0.0
2.4
—
1.5
—
0
5
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
5.8
—
111.5
—
0
5
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(4062490)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
4.2
—
23.7
—
0
13
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
55
520
1.10
0.17
3.8
2.9
estimate
0.0
0.0
—
6
114
(3020682) Albumin/Creatinine [Ratio] in Urine
18
159
1.15
0.16
3.5
4.1
mg/mmol
6.6
17.2
0.82
11
105
(36660697) Celiac disease serology panel - Serum
14
121
1.18
0.16
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
16
180
0.87
0.14
2.3
2.2
ug/g
130.2
65.8
0.36
11
137
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
45
426
1.09
0.13
1.9
2.2
nmol/l
64.6
71.1
0.72
40
398
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
94
960
0.91
0.12
2.9
3.0
mmol/l
1.5
1.5
0.54
85
918
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
146
0.88
0.11
2.5
2.2
u/l
6773.1
6470.5
—
7
62
(3009261) Glucose [Presence] in Urine by Test strip
54
522
1.06
0.08
3.9
3.0
estimate
0.0
0.0
—
6
110
(3013512) EKG study
18
166
1.10
0.08
1.8
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17
157
1.10
0.07
3.2
3.4
mg/l
41.9
121.2
—
10
105
(3005322) IgE [Units/volume] in Serum or Plasma
7
82
0.84
0.07
1.0
1.3
u/ml
77.5
408.4
—
7
75
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
86
1.05
0.07
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
95
964
0.94
0.07
3.0
3.0
mmol/l
4.6
4.8
0.63
87
920
(3000492) Spirometry study
11
99
1.12
0.06
1.5
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
98
967
1.07
0.06
3.3
3.1
mmol/l
2.9
2.9
0.00
91
920
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
25
238
1.06
0.05
2.1
2.6
ng/l
25.0
11.9
—
10
76
(3036481) Cortisol [Moles/volume] in Serum or Plasma
10
109
0.91
0.04
2.1
1.8
nmol/l
416.3
385.4
—
10
104
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
40
391
1.03
0.02
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
156
1.03
0.00
1.1
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
183
0.98
0.00
1.8
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
52
517
1.01
0.00
6.3
4.2
estimate
0.0
0.0
—
5
115
(3022145) Colonoscopy Study observation
10
102
0.98
0.00
1.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
91
914
0.98
0.00
2.5
2.7
mmol/l
1.2
1.2
0.41
82
868
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.6
—
3.8
—
0
7
(3015183) Erythrocyte sedimentation rate
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
0
7
0.00
0.00
0.0
2.7
—
8.3
—
0
7
(3010838) Calcium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.8
—
0
7
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
6
62
0.97
0.00
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
3.1
—
10.1
—
0
7
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
0
8
0.00
0.00
0.0
2.8
—
72.8
—
0
8
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.6
—
104.9
—
0
7
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
22.1
—
0
8
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.4
—
5.1
—
0
5
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.4
—
2.0
—
0
9
(3038515) Glucose [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
2.8
—
6.4
—
0
9
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.6
—
2110.0
—
0
5
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
76
0.92
0.00
18.6
3.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
506.6
—
0
5
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
81
0.99
0.00
1.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
0.8
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
1.4
—
0
5
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
28.0
—
0
5
(3008037) Lactate [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
2.8
—
1.0
—
0
9
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
14.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
56
0.89
0.00
4.2
2.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
6
0.00
-0.00
0.0
2.5
—
25.3
—
0
6
(3010503) CD19 cells [#/volume] in Blood
0
6
0.00
-0.00
0.0
2.3
—
0.3
—
0
6
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
-0.00
0.0
1.2
—
91.8
—
0
6
(40768795) Lymph node Pathology biopsy report
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint MATERNCAREFETUSALCO and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have MATERNCAREFETUSALCO.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: MATERNCAREFETUSALCO – Maternal care for (suspected) damage to fetus from alcohol
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data